Cymabay Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Cymabay Therapeutics shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Cymabay Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cymabay Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Cymabay Therapeutics by T. Rowe Price Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $106M | 4.5M | 23.62 |
2023-09-30 | $28M | 1.9M | 14.91 |
2023-06-30 | $1.0M | 94k | 10.95 |
2023-03-31 | $633k | 73k | 8.72 |
2022-12-31 | $811k | 129k | 6.27 |
2022-03-31 | $342k | 110k | 3.11 |
2021-12-31 | $327k | 97k | 3.38 |
2021-09-30 | $502k | 138k | 3.65 |
2021-06-30 | $600k | 138k | 4.36 |
2021-03-31 | $315k | 69k | 4.54 |
2020-12-31 | $275k | 48k | 5.73 |
2020-09-30 | $171k | 24k | 7.26 |
2018-09-30 | $4.6M | 411k | 11.08 |
2018-06-30 | $9.2M | 687k | 13.42 |
2018-03-31 | $9.1M | 700k | 12.99 |